The choice of proton pump inhibitor in terms of efficacy and safety in a particular patient

dc.contributor.authorUmrzaqov Odil bek
dc.date.accessioned2026-01-02T11:32:48Z
dc.date.issued2023-03-30
dc.description.abstractProton pump inhibitors are a diverse class of drugs with unique acid suppression properties . The aim of this work was to present the therapeutic benefits of rabeprazole and pantoprazole in clinical practice. Numerous studies have demonstrated the high efficacy of proton pump inhibitors and the relative safety of taking these drugs. However, it is necessary to increase the awareness of doctors and pharmacists about the possibility of complications during therapy with proton pump inhibitors in a polymorbid patient. The choice of proton pump inhibitors should be based on the clinical situation, comorbidity and therapy, the presence of risk factors in the patient, the speed and stability of the drug effect.
dc.formatapplication/pdf
dc.identifier.urihttps://geniusjournals.org/index.php/emrp/article/view/3719
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/77530
dc.language.isoeng
dc.publisherGenius Journals
dc.relationhttps://geniusjournals.org/index.php/emrp/article/view/3719/3146
dc.sourceEurasian Medical Research Periodical; Vol. 18 (2023): EMRP; 123-128
dc.source2795-7624
dc.subjectproton pump inhibitors
dc.subjectrabeprozole
dc.subjectpantaprazole
dc.titleThe choice of proton pump inhibitor in terms of efficacy and safety in a particular patient
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
bek_2023_the_choice_of_proton_pump_inhibitor_in_t.pdf
item.page.filesection.size
263.78 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections